Evidence map›Paper›PMID 37696923›Full record

ArticleLeukemia2023

Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia.

Alisa Olkinuora, Taina T Nieminen, Suvi Douglas, Anni Kauppinen, Mika Kontro, Juho Väänänen, Matti Kankainen, Ari Ristimäki, Markus Mäkinen, Päivi Lahermo and 10 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Alisa OlkinuoraDepartment of Medical and Clinical Genetics, University of Helsinki, 00014, Helsinki, Finland. alisa.olkinuora@helsinki.fi.ORCID 0000-0003-3987-9924
Taina T NieminenDepartment of Medical and Clinical Genetics, University of Helsinki, 00014, Helsinki, Finland. taina.nieminen@helsinki.fi.ORCID 0000-0002-7273-4578
Suvi DouglasDepartment of Medical and Clinical Genetics, University of Helsinki, 00014, Helsinki, Finland.ORCID 0000-0003-4412-688X
Anni KauppinenDepartment of Medical and Clinical Genetics, University of Helsinki, 00014, Helsinki, Finland.
Mika KontroDepartment of Hematology, Helsinki University Hospital, Comprehensive Cancer Center and University of Helsinki, 00014, Helsinki, Finland.ORCID 0000-0001-6353-0664
Juho VäänänenApplied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland.
Matti KankainenHUSLAB Laboratory of Genetics, HUS Diagnostic Center, HUS, Helsinki University Hospital, 00029, Helsinki, Finland.ORCID 0000-0002-4714-9481
Ari RistimäkiApplied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland.
Markus MäkinenResearch Unit of Cancer and Translational Medicine, Department of Pathology, 90014, University of Oulu, and Department of Pathology, Oulu University Hospital, OYS, 90029, Oulu, Finland.
Päivi LahermoHiLIFE Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 00014, Helsinki, Finland.
Caroline HeckmanHiLIFE Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 00014, Helsinki, Finland.ORCID 0000-0002-4324-8706
Janna SaarelaHiLIFE Institute for Molecular Medicine Finland (FIMM), University of Helsinki, 00014, Helsinki, Finland.
Milla SalonenDepartment of Medical and Clinical Genetics, University of Helsinki, 00014, Helsinki, Finland.ORCID 0000-0002-9901-7923
Anna LepistöApplied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland.
Heikki JärvinenDepartment of Abdominal Surgery, Helsinki University Hospital and University of Helsinki, 00014, Helsinki, Finland.
Jukka-Pekka MecklinDepartment of Education & Research and Surgery, Jyväskylä Central Hospital, 40620, Jyväskylä, Finland.
Outi KilpivaaraDepartment of Medical and Clinical Genetics, University of Helsinki, 00014, Helsinki, Finland.ORCID 0000-0001-8467-2100
Ulla Wartiovaara-KauttoApplied Tumor Genomics Research Program, Faculty of Medicine, University of Helsinki, 00014, Helsinki, Finland.
Kimmo PorkkaDepartment of Hematology, Helsinki University Hospital, Comprehensive Cancer Center and University of Helsinki, 00014, Helsinki, Finland. kimmo.porkka@helsinki.fi.
Päivi PeltomäkiDepartment of Medical and Clinical Genetics, University of Helsinki, 00014, Helsinki, Finland. paivi.peltomaki@helsinki.fi.ORCID 0000-0001-8819-2980

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colorectal NeoplasmsHumansRisk Factors

Identifiers

PMID37696923
PMCPMC10624609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.